+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Emergent BioSolutions, Inc. - logo

Emergent BioSolutions manufactures immunobiotics such as vaccines and immune globulins that assist the body’s immune system. The company’s biodefense segment develops drugs such as BioThrax, a vaccine for the prevention of anthrax, for use against biological agents. Other products in preclinical development include drugs for the treatment of patients exposed to anthrax and botulinum toxin. The company, which was founded in 1998, is based in Rockville, Maryland.

From
From
Global Markets for Vaccine Technologies - Product Thumbnail Image

Global Markets for Vaccine Technologies

  • Report
  • January 2024
  • 213 Pages
  • Global
From
Shigellosis - Pipeline Insight, 2025 - Product Thumbnail Image

Shigellosis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Vaccine Contract Manufacturing Market Report 2023-2033 - Product Thumbnail Image

Vaccine Contract Manufacturing Market Report 2023-2033

  • Report
  • May 2023
  • 375 Pages
  • Global
From
Vaccine Sales Market Report 2023-2033 - Product Thumbnail Image

Vaccine Sales Market Report 2023-2033

  • Report
  • June 2023
  • 364 Pages
  • Global
From
From
From
Anthrax Vaccine - Global Strategic Business Report - Product Thumbnail Image

Anthrax Vaccine - Global Strategic Business Report

  • Report
  • July 2025
  • 375 Pages
  • Global
From
Combination Vaccines - Global Strategic Business Report - Product Thumbnail Image

Combination Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 373 Pages
  • Global
From
Live Attenuated Vaccines - Global Strategic Business Report - Product Thumbnail Image

Live Attenuated Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 563 Pages
  • Global
From
Oral Typhoid Vaccines - Global Strategic Business Report - Product Thumbnail Image

Oral Typhoid Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 183 Pages
  • Global
From
Bacterial Vaccines - Global Strategic Business Report - Product Thumbnail Image

Bacterial Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 490 Pages
  • Global
From
Adult Vaccines - Global Strategic Business Report - Product Thumbnail Image

Adult Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 377 Pages
  • Global
From
Adenovirus Vaccines - Global Strategic Business Report - Product Thumbnail Image

Adenovirus Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 279 Pages
  • Global
From
Preventable Vaccines - Global Strategic Business Report - Product Thumbnail Image

Preventable Vaccines - Global Strategic Business Report

  • Report
  • July 2025
  • 391 Pages
  • Global
From
Loading Indicator